This is the first study to investigate and compare genetic background (BRAF V600E, RET/PTC rearrangements, and RAS mutations) in differentiated thyroid carcinomas from iodine‐rich and iodine‐deficient countries. Here, BRAF is linked to thyroid gland carcinoma.